AGT and breast carcinoma: Koh et al. [5] found that individuals possessing low-activity ACE alleles were at a reduced risk of breast cancer, suggesting that inhibition of the angiotensin II effect by blockade of ACE could be potential targets for the prevention and treatment of breast cancer.